SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
News-Medical.Net on MSN
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
Chronic pain may play a significant role in increasing the risk of developing high blood pressure. How long the pain lasts ...
Parade on MSN
This one common habit actually helps 'disrupt pain pathways,' Cleveland Clinic expert reveals
Recent studies are pointing to the fact that kindness can decrease pain and lessen stress. As Dr. Kapoor notes, pain is ...
Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. More Americans use cannabis to treat chronic pain as an ...
A fluorescence microscopy image displays iPSC-derived peripheral pain-sensing neurons (nociceptors) stained for TUJ1 (cyan) and TRKA (magenta). The cells, which form the basis of SereNeuro’s SN101 ...
Patients in pain may not associate psychologists with an avenue for help, yet their expertise can be a part of an innovative ...
Oversubscribed round demonstrates strong investor confidence in Lin Health's neuroscience-based approach to chronic pain ...
A new study has found that people living with chronic pain tend to be more perfectionistic, less self-compassionate and – depending on the measure – less confident in their ability to cope. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback